• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心包穿刺后渗出性缩窄性心包炎:发生率、相关表现及自然病史。

Effusive-Constrictive Pericarditis After Pericardiocentesis: Incidence, Associated Findings, and Natural History.

机构信息

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota; Department of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Republic of Korea.

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.

出版信息

JACC Cardiovasc Imaging. 2018 Apr;11(4):534-541. doi: 10.1016/j.jcmg.2017.06.017. Epub 2017 Oct 5.

DOI:10.1016/j.jcmg.2017.06.017
PMID:28917680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6309441/
Abstract

OBJECTIVES

This study sought to investigate the incidence, associated findings, and natural history of effusive-constrictive pericarditis (ECP) after pericardiocentesis.

BACKGROUND

ECP is characterized by the coexistence of tense pericardial effusion and constriction of the heart by the visceral pericardium. Echocardiography is currently the main diagnostic tool in the assessment of pericardial disease, but limited data have been published on the incidence and prognosis of ECP diagnosed by echo-Doppler.

METHODS

A total of 205 consecutive patients undergoing pericardiocentesis at Mayo Clinic, Rochester, Minnesota, were divided into 2 groups (ECP and non-ECP) based on the presence or absence of post-centesis echocardiographic findings of constrictive pericarditis. Clinical, laboratory, and imaging characteristics were compared.

RESULTS

ECP was subsequently diagnosed in 33 patients (16%) after pericardiocentesis. Overt clinical cardiac tamponade was present in 52% of ECP patients and 36% of non-ECP patients (p = 0.08). Post-procedure hemopericardium was more frequent in the ECP group (33% vs. 13%; p = 0.003), and a higher percentage of neutrophils and lower percentage of monocytes were noted on pericardial fluid analysis in those patients. Clinical and laboratory findings were otherwise similar. Baseline early diastolic mitral septal annular velocity was significantly higher in the ECP group. Before pericardiocentesis, respiratory variation of mitral inflow velocity, expiratory diastolic flow reversal of hepatic vein, and respirophasic septal shift were significantly more frequent in the ECP group. Fibrinous or loculated effusions were also more frequently observed in the ECP group. Four deaths occurred in the ECP group; all 4 patients had known malignancies. During median follow-up of 3.8 years (interquartile range: 0.5 to 8.3 years), only 2 patients required pericardiectomy for persistent constrictive features and symptoms.

CONCLUSIONS

In a large cohort of unselected patients undergoing pericardiocentesis, 16% were found to have ECP. Pre-centesis echocardiographic findings might identify such patients. Long-term prognosis in those patients remains good, and pericardiectomy was rarely required.

摘要

目的

本研究旨在探讨心包穿刺后渗出性缩窄性心包炎(ECP)的发生率、相关表现和自然病史。

背景

ECP 的特征是心包腔内存在紧张的积液,同时心脏被内脏心包所限制。超声心动图是目前评估心包疾病的主要诊断工具,但关于经超声心动图-多普勒诊断的 ECP 发生率和预后的数据有限。

方法

明尼苏达州罗切斯特市梅奥诊所的 205 例连续心包穿刺患者,根据心包穿刺后是否存在缩窄性心包炎的超声心动图表现,分为 ECP 组和非 ECP 组。比较两组的临床、实验室和影像学特征。

结果

心包穿刺后,33 例(16%)患者被诊断为 ECP。ECP 组中有 52%的患者出现明显的临床心脏压塞,而非 ECP 组中有 36%的患者出现(p=0.08)。ECP 组的心包积血更为常见(33% vs. 13%;p=0.003),心包积液分析中中性粒细胞比例较高,单核细胞比例较低。其他临床和实验室检查结果相似。ECP 组舒张早期二尖瓣环速度明显较高。心包穿刺前,ECP 组的二尖瓣流入速度呼吸变异、肝静脉呼气期舒张期血流逆转和呼吸性室间隔移位更为频繁。ECP 组也更常出现纤维蛋白性或分隔性积液。ECP 组有 4 例死亡,均为已知恶性肿瘤。在中位随访 3.8 年(四分位距:0.5 至 8.3 年)期间,仅 2 例因持续缩窄性特征和症状而行心包切除术。

结论

在接受心包穿刺的大量未选择患者中,有 16%的患者被发现患有 ECP。心包穿刺前的超声心动图表现可能有助于识别此类患者。这些患者的长期预后良好,很少需要心包切除术。

相似文献

1
Effusive-Constrictive Pericarditis After Pericardiocentesis: Incidence, Associated Findings, and Natural History.心包穿刺后渗出性缩窄性心包炎:发生率、相关表现及自然病史。
JACC Cardiovasc Imaging. 2018 Apr;11(4):534-541. doi: 10.1016/j.jcmg.2017.06.017. Epub 2017 Oct 5.
2
Pre- and post-pericardiocentesis echo-Doppler features of effusive-constrictive pericarditis compared with cardiac tamponade and constrictive pericarditis.比较渗出性缩窄性心包炎与心脏压塞和缩窄性心包炎的心包穿刺术前及术后超声心动图-多普勒特征。
Eur Heart J Cardiovasc Imaging. 2019 Mar 1;20(3):298-306. doi: 10.1093/ehjci/jey081.
3
Effusive-Constrictive Pericarditis: Doppler Findings.渗出性缩窄性心包炎:多普勒表现。
Curr Cardiol Rep. 2019 Nov 22;21(11):144. doi: 10.1007/s11886-019-1243-4.
4
Effusive-Constrictive Pericarditis.渗出 - 缩窄性心包炎
Cardiol Clin. 2017 Nov;35(4):551-558. doi: 10.1016/j.ccl.2017.07.008.
5
Effusive-constrictive pericarditis.渗出性缩窄性心包炎。
Heart Fail Rev. 2013 May;18(3):277-87. doi: 10.1007/s10741-012-9308-0.
6
Effusive-constrictive pericarditis.渗出性缩窄性心包炎
N Engl J Med. 2004 Jan 29;350(5):469-75. doi: 10.1056/NEJMoa035630.
7
Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion.结核性心包积液患者渗出性缩窄性心包炎的患病率、血液动力学和细胞因子谱。
PLoS One. 2013 Oct 14;8(10):e77532. doi: 10.1371/journal.pone.0077532. eCollection 2013.
8
Transitory effusive-constrictive pericarditis.一过性渗出性缩窄性心包炎。
Am J Emerg Med. 2018 Mar;36(3):524.e1-524.e6. doi: 10.1016/j.ajem.2017.11.047. Epub 2017 Nov 21.
9
Successful Visceral and Parietal Pericardiectomy for Refractory Effusive-Constrictive Pericarditis: A Challenging Case Report.成功施行内脏和壁层心包切除术治疗难治性渗出缩窄性心包炎:一例挑战性病例报告。
Am J Case Rep. 2024 Jun 5;25:e943979. doi: 10.12659/AJCR.943979.
10
A case of effusive-constrictive pericarditis after cardiac surgery.心脏手术后发生渗出性缩窄性心包炎1例。
Mayo Clin Proc. 2001 May;76(5):555-8. doi: 10.4065/76.5.555.

引用本文的文献

1
Post-infarct effusive-constrictive pericarditis with a percutaneous left ventricular assist device: a case report.心肌梗死后伴有经皮左心室辅助装置的渗出性缩窄性心包炎:一例报告
Eur Heart J Case Rep. 2025 Jul 10;9(7):ytaf326. doi: 10.1093/ehjcr/ytaf326. eCollection 2025 Jul.
2
Old and New Biomarkers in Idiopathic Recurrent Acute Pericarditis (IRAP): Prognosis and Outcomes.特发性复发性急性心包炎(IRAP)中的新旧生物标志物:预后与结局
Curr Cardiol Rep. 2025 Jan 11;27(1):17. doi: 10.1007/s11886-024-02170-y.
3
Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging.

本文引用的文献

1
2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).2015年欧洲心脏病学会(ESC)心包疾病诊断和管理指南:欧洲心脏病学会(ESC)心包疾病诊断和管理工作组 认可机构:欧洲心胸外科学会(EACTS)
Eur Heart J. 2015 Nov 7;36(42):2921-2964. doi: 10.1093/eurheartj/ehv318. Epub 2015 Aug 29.
2
Constrictive pericarditis--a curable diastolic heart failure.缩窄性心包炎——一种可治愈的舒张性心力衰竭。
Nat Rev Cardiol. 2014 Sep;11(9):530-44. doi: 10.1038/nrcardio.2014.100. Epub 2014 Jul 29.
3
心包疾病:多模态心脏成像新概念和新进展的国际立场声明。
JACC Cardiovasc Imaging. 2024 Aug;17(8):937-988. doi: 10.1016/j.jcmg.2024.04.010.
4
Chronic pericarditis and recurrent pericardial effusion of unknown origin in a kitten: a case report.一只小猫不明原因的慢性心包炎和复发性心包积液:病例报告
Front Vet Sci. 2024 Jun 17;11:1347083. doi: 10.3389/fvets.2024.1347083. eCollection 2024.
5
Successful Visceral and Parietal Pericardiectomy for Refractory Effusive-Constrictive Pericarditis: A Challenging Case Report.成功施行内脏和壁层心包切除术治疗难治性渗出缩窄性心包炎:一例挑战性病例报告。
Am J Case Rep. 2024 Jun 5;25:e943979. doi: 10.12659/AJCR.943979.
6
Surviving the Storm: Cardiac Tamponade and Effusive Constrictive Pericarditis Complicated by Pericardial Decompression Syndrome Induced by COVID-19 Infection in the Setting of Newly Diagnosed Acute Myeloid Leukemia (AML).挺过风暴:在新诊断的急性髓系白血病(AML)背景下,新冠病毒感染诱发心包减压综合征并发心脏压塞和渗出性缩窄性心包炎
Cureus. 2024 Mar 22;16(3):e56710. doi: 10.7759/cureus.56710. eCollection 2024 Mar.
7
Rapid Fatal Progression and Autopsy Findings of Effusive-Constrictive Pericarditis With Hypertrophic Cardiomyopathy.伴有肥厚型心肌病的渗出性缩窄性心包炎的快速致死性进展及尸检结果
Circ Rep. 2023 Jul 21;5(9):365-366. doi: 10.1253/circrep.CR-23-0061. eCollection 2023 Sep 8.
8
Cardiac tamponade.心脏压塞。
Nat Rev Dis Primers. 2023 Jul 20;9(1):36. doi: 10.1038/s41572-023-00446-1.
9
-related effusive-constrictive pericarditis diagnosed with echocardiography: A case report.超声心动图诊断的相关渗出性缩窄性心包炎:一例报告
World J Clin Cases. 2022 Jul 26;10(21):7577-7584. doi: 10.12998/wjcc.v10.i21.7577.
10
Cardiogenic shock among cancer patients.癌症患者的心源性休克。
Front Cardiovasc Med. 2022 Aug 22;9:932400. doi: 10.3389/fcvm.2022.932400. eCollection 2022.
Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion.
结核性心包积液患者渗出性缩窄性心包炎的患病率、血液动力学和细胞因子谱。
PLoS One. 2013 Oct 14;8(10):e77532. doi: 10.1371/journal.pone.0077532. eCollection 2013.
4
Management of pericardial effusion.心包积液的处理。
Eur Heart J. 2013 Apr;34(16):1186-97. doi: 10.1093/eurheartj/ehs372. Epub 2012 Nov 2.
5
Effusive-constrictive pericarditis.渗出性缩窄性心包炎。
Heart Fail Rev. 2013 May;18(3):277-87. doi: 10.1007/s10741-012-9308-0.
6
The prevalence and outcome of effusive constrictive pericarditis: a systematic review of the literature.渗出性缩窄性心包炎的患病率及预后:文献系统综述
Cardiovasc J Afr. 2012 Jun;23(5):281-5. doi: 10.5830/CVJA-2011-072. Epub 2012 Jan 12.
7
Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study.心脏磁共振成像心包晚期钆增强和炎症标志物升高可预测抗炎药物治疗后缩窄性心包炎的可逆性:一项初步研究。
Circulation. 2011 Oct 25;124(17):1830-7. doi: 10.1161/CIRCULATIONAHA.111.026070. Epub 2011 Oct 3.
8
Pericardial disease: diagnosis and management.心包疾病:诊断与管理。
Mayo Clin Proc. 2010 Jun;85(6):572-93. doi: 10.4065/mcp.2010.0046.
9
Effusive constrictive pericarditis: 2D, 3D echocardiography and MRI imaging.渗出性缩窄性心包炎:二维、三维超声心动图及磁共振成像
Echocardiography. 2007 Nov;24(10):1110-4. doi: 10.1111/j.1540-8175.2007.00505.x.
10
The management of tuberculous pericardial effusion: experience in 233 consecutive patients.结核性心包积液的管理:233例连续患者的经验
Cardiovasc J S Afr. 2007 Jan-Feb;18(1):20-5.